Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    End-stage Lung Disease Awaiting Lung Transplant
  • Age: Between 18 years - 120 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Informed consent is given for participation in the Study by the patient or patient’s designated representative.
    2. Patient undergoes lung transplantation.

You may not be eligible for this study if the following are true:

    1. Patients listed for same-side lung re-transplantation.
    2. Patients listed for multiple-organ transplantation including lung and any other organ.
    3. Patients listed for live donor lobar lung transplant.
    4. Patients positive for human immunodeficiency virus (HIV) or Burkholderia cepacia infection.
    5. Patient receives a standard of care (non-EVLP) lung transplant but does not match to an EVLP subject based on the criteria for control matching.
    6. Participating in another interventional trial.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.